Why it was recalled
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Product description
Avastin, solution, 1.25 mg/0.05mL, Injectable, Syringe, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Lot numbers, UPCs & expiration codes
Lot 04202015:49@1, Expiry date: 5/20/2015; Lot 04272015:06@6, Expiry date: 6/2/2015; Lot 04282015:16@13, Expiry date: 6/12/2015; Lot 05062015:56@3, Expiry date: 5/24/2015;
Where it was sold
MT and ND
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1119-2015
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- May 15, 2015
- FDA report date
- Jun 17, 2015
- Quantity
- 259/0.05 mL Syringes
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Montana Compounding Pharmacy
Original FDA data
Every field from FDA enforcement report D-1119-2015, exactly as published.
Show all FDA fields
- City
- Missoula
- State
- MT
- Status
- Terminated
- Country
- United States
- Event ID
- 71275
- Address
- 111 N Higgins Ave
- Code information
- Lot 04202015:49@1, Expiry date: 5/20/2015; Lot 04272015:06@6, Expiry date: 6/2/2015; Lot 04282015:16@13, Expiry date: 6/12/2015; Lot 05062015:56@3, Expiry date: 5/24/2015;
- Postal code
- 59802-4437
- Report date
- Jun 17, 2015
- Product type
- Drugs
- Recall number
- D-1119-2015
- Classification
- Class II
- Recalling firm
- Montana Compounding Pharmacy
- Product quantity
- 259/0.05 mL Syringes
- Termination date
- Dec 20, 2016
- Reason for recall
- Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Avastin, solution, 1.25 mg/0.05mL, Injectable, Syringe, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
- Distribution pattern
- MT and ND
- Recall initiation date
- May 15, 2015
- Initial firm notification
- Letter
- Center classification date
- Jun 9, 2015